SAN DIEGO, Aug. 3, 2020 /PRNewswire/ – Aspen Neuroscience, a private biotechnology company developing the first autologous neuron replacement therapy to treat Parkinson’s disease, today announced that Dr. Jeanne Loring, co-founder and Chief Scientific Officer, will transition to the role of Special Advisor to the Company’s Research and Development Committee. Dr. Loring is Professor emeritus of the Scripps Research Institute where her research on the genomics of induced pluripotent stem cells launched Aspen’s program for Parkinson’s disease therapy. She is an internationally renowned pioneer in stem cell technology and patient advocacy.